Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pichert

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reviews|January 1, 1995
High-dose chemotherapy and autologous bone marrow transplantation for malignant lymphomasR A Stahel, L M Jost, G Pichert, et al.
Hematological Oncology|September 2, 1998
T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cellsD Schmitter, M Koss, E Niederer, et al.
Clinical and Experimental Dermatology|October 31, 2009
Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretinS J Robertson, S J Bashir, G Pichert, et al.
Blood|October 1, 1994
Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemiaG Pichert, E P Alyea, R J Soiffer, et al.
British Journal of Cancer|July 1, 1990
Thyroiditis after treatment with interleukin-2 and interferon alpha-2aG Pichert, L M Jost, L Zöbeli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomasG Pichert, D Schmitter, L Widmer, et al.
Leukemia & Lymphoma|March 1, 1995
Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cellsM J Robertson, T J Manley, G Pichert, et al.
Schweizerische Medizinische Wochenschrift|May 8, 1993
[5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence]L M Jost, G Pichert, M Reichlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignanciesR A Stahel, L M Jost, T Cerny, et al.
Journal of Medical Genetics|February 20, 2007
Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplificationD Gareth R Evans, R T Ramsden, A Shenton, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reviews|January 1, 1995
High-dose chemotherapy and autologous bone marrow transplantation for malignant lymphomasR A Stahel, L M Jost, G Pichert, et al.
Hematological Oncology|September 2, 1998
T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cellsD Schmitter, M Koss, E Niederer, et al.
Clinical and Experimental Dermatology|October 31, 2009
Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretinS J Robertson, S J Bashir, G Pichert, et al.
Blood|October 1, 1994
Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemiaG Pichert, E P Alyea, R J Soiffer, et al.
British Journal of Cancer|July 1, 1990
Thyroiditis after treatment with interleukin-2 and interferon alpha-2aG Pichert, L M Jost, L Zöbeli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomasG Pichert, D Schmitter, L Widmer, et al.
Leukemia & Lymphoma|March 1, 1995
Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cellsM J Robertson, T J Manley, G Pichert, et al.
Schweizerische Medizinische Wochenschrift|May 8, 1993
[5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence]L M Jost, G Pichert, M Reichlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignanciesR A Stahel, L M Jost, T Cerny, et al.
Journal of Medical Genetics|February 20, 2007
Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplificationD Gareth R Evans, R T Ramsden, A Shenton, et al.
Pageof 3